TRIAL - EMBASE on Ovid
Embase increases the discovery of biomedical evidence to support critical life sciences functions, delivering relevant, up-to-date biomedical information to the global biomedical research community. It allows users to successfully perform critical functions such as pharmacovigilance, as well as generating high-quality systematic reviews in support of evidence-based medicine and drug and medical device efficacy studies.
The trial is active between the 2nd July and the 25th July 2019 and can be accessed here.
If you experience any problems filling in/submitting the survey form or accessing Embase on OVID, fill in the Electronic Resources Access Problems form and we will investigate and get back to you as soon as possible.